Kurs & Likviditet
Kalender
2024-08-14 | Kvartalsrapport 2024-Q2 |
2024-03-07 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2024-03-06 | Årsstämma |
2024-02-06 | Bokslutskommuniké 2023 |
2023-08-15 | Kvartalsrapport 2023-Q2 |
2023-03-09 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2023-03-08 | Årsstämma |
2023-02-07 | Bokslutskommuniké 2022 |
2022-08-16 | Kvartalsrapport 2022-Q2 |
2022-03-11 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2022-03-10 | Årsstämma |
2022-02-08 | Bokslutskommuniké 2021 |
2021-08-12 | Kvartalsrapport 2021-Q2 |
2021-03-08 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2021-03-05 | Årsstämma |
2021-02-09 | Bokslutskommuniké 2020 |
2020-08-17 | Kvartalsrapport 2020-Q2 |
2020-03-11 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2020-03-10 | Årsstämma |
2020-02-04 | Bokslutskommuniké 2019 |
2019-08-14 | Kvartalsrapport 2019-Q2 |
2019-03-20 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2019-03-19 | Årsstämma |
2019-02-19 | Bokslutskommuniké 2018 |
2018-08-15 | Kvartalsrapport 2018-Q2 |
2018-03-23 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2018-03-22 | Årsstämma |
2018-02-22 | Bokslutskommuniké 2017 |
2017-08-14 | Kvartalsrapport 2017-Q2 |
2017-05-09 | Kvartalsrapport 2017-Q1 |
2017-03-28 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2017-03-27 | Årsstämma |
2017-02-23 | Bokslutskommuniké 2016 |
2016-11-10 | Kvartalsrapport 2016-Q3 |
2016-08-17 | Kvartalsrapport 2016-Q2 |
2016-05-25 | Split DEMANT 1:5 |
2016-05-10 | Kvartalsrapport 2016-Q1 |
2016-04-08 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2016-04-07 | Årsstämma |
2016-03-01 | Bokslutskommuniké 2015 |
2015-11-12 | Kvartalsrapport 2015-Q3 |
2015-08-14 | Kvartalsrapport 2015-Q2 |
2015-05-07 | Kvartalsrapport 2015-Q1 |
2015-04-10 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2015-04-09 | Årsstämma |
2015-02-26 | Bokslutskommuniké 2014 |
2014-11-13 | Kvartalsrapport 2014-Q3 |
2014-08-14 | Kvartalsrapport 2014-Q2 |
2014-05-08 | Kvartalsrapport 2014-Q1 |
2014-04-10 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2014-04-09 | Årsstämma |
2014-02-27 | Bokslutskommuniké 2013 |
2013-11-05 | Kvartalsrapport 2013-Q3 |
2013-08-14 | Kvartalsrapport 2013-Q2 |
2013-05-07 | Kvartalsrapport 2013-Q1 |
2013-04-10 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2013-04-09 | Årsstämma |
2013-02-26 | Bokslutskommuniké 2012 |
2012-11-07 | Kvartalsrapport 2012-Q3 |
2012-08-16 | Kvartalsrapport 2012-Q2 |
2012-05-10 | Kvartalsrapport 2012-Q1 |
2012-04-12 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2012-04-11 | Årsstämma |
2012-02-29 | Bokslutskommuniké 2011 |
2011-11-10 | Kvartalsrapport 2011-Q3 |
2011-08-19 | Kvartalsrapport 2011-Q2 |
2011-05-12 | Kvartalsrapport 2011-Q1 |
2011-04-14 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
2011-04-13 | Årsstämma |
2010-11-16 | Kvartalsrapport 2010-Q3 |
2010-04-08 | X-dag ordinarie utdelning DEMANT 0.00 DKK |
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Medicinteknik |
1.8.2024 11:49:37 CEST | Demant A/S | Investor News
Investor news | 1 August 2024 |
Restated comparative figures for 2023
On 5 February 2024, Demant announced the decision to undertake a strategic review of its Communications business segment. In accordance with IFRS 5 – Non-current Assets Held for Sale and Discontinued Operations and as previously communicated, Communications is therefore recognised in the Group’s financial reporting as a discontinued operation together with Hearing Implants, and comparative figures for 2023 are restated to reflect this. To help reconcile these figures, we attach restated income statements and statement of free cash flow before acquisitions (unaudited) for continuing operations for the following reporting periods: H1 2023, H2 2023 and FY 2023.
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 | Other contacts: René Schneider, CFO Peter Pudselykke, Head of Investor Relations Henrik Axel Lynge Buchter, Manager of External Communications |
Contacts
- Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.